Howard S. Bregman

机构：Recludix Pharma (United States) · ORCID：0000-0001-8062-9770

发表论文 64 篇 · 总被引 3332 次 · h-index 28

代表论文

• Electrophilic properties of itaconate and derivatives regulate the IκBζ–ATF3 inflammatory axis (2018 · Nature · 被引 752)
• An Organometallic Protein Kinase Inhibitor Pharmacologically Activates p53 and Induces Apoptosis in Human Melanoma Cells (2007 · Cancer Research · 被引 235)
• Ruthenium Half‐Sandwich Complexes Bound to Protein Kinase Pim‐1 (2006 · Angewandte Chemie International Edition · 被引 234)
• Rapid Access to Unexplored Chemical Space by Ligand Scanning around a Ruthenium Center: Discovery of Potent and Selective Protein Kinase Inhibitors (2005 · Journal of the American Chemical Society · 被引 151)
• Exploring Chemical Space with Organometallics: Ruthenium Complexes as Protein Kinase Inhibitors (2007 · Synlett · 被引 142)
• Crystal structures of human glycine receptor α3 bound to a novel class of analgesic potentiators (2016 · Nature Structural & Molecular Biology · 被引 128)